Pain after cesarean section
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. The puerperae and their family members voluntarily use the electronic analgesia pump at their own expense and sign the informed consent form; 2. Single fetus and full-term pregnant women; 3. The blood coagulation function was normal: platelets 125-350x10^9/L, PT 9.4-12.5 s, APTT 25.1-36.5 s.
Exclusion criteria
Exclusion criteria: 1. Refuse to use electronic analgesia pump; 2. Have a history of local anesthetic allergy and opioid abuse; 3. Severe organic disease patients: (1) Cardiovascular disease: cardiac dysfunction, severe arrhythmia, acute coronary syndrome, hypertension crisis, aortic aneurysm or aortic dissection, acute pulmonary embolism; (2) Respiratory system disease: respiratory dysfunction, bronchiectasis with hemoptysis, status asthma; (3) Digestive system disease: liver cirrhosis decompensated, acute bleeding necrotizing pancreatitis, liver failure, acute suppurative obstructive cholangitis; (4) Renal dysfunction; (5) Nervous system diseases: severe cerebrovascular disease, intracranial organic disease, grand mal seizures, myasthenia gravis; (6) Severe endocrine and metabolic diseases combined with dysfunction of important organs; (7) Blood system diseases: aplastic anemia, severe anemia, leukemia, myelodysplastic syndrome, lymphoma, multiple myeloma, etc.; 4. Mental illness, communication disorder.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain scores;Cumulative dose of nalbuphine;Analgesic Remedy Situation;The occurrence of adverse reactions; | — |
Secondary
| Measure | Time frame |
|---|---|
| Number of sleep disturbances at night due to insufficient analgesia;first intestinal exhaust time after operation;the length of hospital stay; | — |
Countries
China
Contacts
ZhongDa Hospital Southeast University